(Q40651786)

22 September 2017

title

Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents (English)

1 reference

22 September 2017

0 references

0 references

Lieven J Stuyver

1

1 reference

22 September 2017

Stefania Lostia

2

1 reference

22 September 2017

Steven E Patterson

3

1 reference

22 September 2017

Jeremy L Clark

4

1 reference

22 September 2017

Kyoichi A Watanabe

5

1 reference

22 September 2017

Michael J Otto

6

1 reference

22 September 2017

Krzysztof W Pankiewicz

7

1 reference

22 September 2017

publication date

1 November 2002

1 reference

Antiviral Chemistry & Chemotherapy

22 September 2017

published in

1 reference

22 September 2017

volume

13

1 reference

22 September 2017

issue

6

1 reference

22 September 2017

page(s)

345-352

1 reference

Mycophenolate mofetil and its mechanisms of action

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Mechanism of action of a pestivirus antiviral compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Oxidation of α,β-un saturated aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Comparisons of the pestivirus bovine viral diarrhoea virus with members of the flaviviridae

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

New therapeutic strategies for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

VX-497: a novel, selective IMPDH inhibitor and immunosuppressive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Mechanism of action of ribavirin in the combination treatment of chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Synthesis of a methylenebis(phosphonate) analogue of mycophenolic adenine dinucleotide: a glucuronidation-resistant MAD analogue of NAD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Preparation of Carboxylic Acids from Aldehydes (Including Hydroxylated Benzaldehydes) by Oxidation with Chlorite

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogues stable to phosphodiesterase hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

High-level expression of hepatitis C virus (HCV) structural proteins by a chimeric HCV/BVDV genome propagated as a BVDV pseudotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

A new synthetic methodology for tiazofurin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Anti-viral effect of interferon-alpha on bovine viral diarrhea virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Effect of cyclosporine withdrawal on mycophenolic acid pharmacokinetics in kidney transplant recipients with deteriorating renal function: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Antiviral activities and cellular toxicities of modified 2',3'-dideoxy-2',3'-didehydrocytidine analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Ribonucleoside Analogue That Blocks Replication of Bovine Viral Diarrhea and Hepatitis C Viruses in Culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Tiazofurin: biological effects and clinical uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Mizoribine: mode of action and effects in clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300602

10.1177/095632020201300602

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference